Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease.
about
Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies.Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia.Rodent models in neuroscience research: is it a rat race?Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia PharmacotherapyInvestigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.Mouse genetic models for prepulse inhibition: an early reviewSex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studiesAssessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington disease.Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous systemOnset and progression of behavioral and molecular phenotypes in a novel congenic R6/2 line exhibiting intergenerational CAG repeat stability.Evidence for Startle Effects due to Externally Induced Lower Limb Movements: Implications in Neurorehabilitation.Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats.Dependence of the Startle Response on Temporal and Spectral Characteristics of Acoustic Modulatory Influences in Rats and GerbilsFunctional Dissociation of Group III Metabotropic Glutamate Receptors Revealed by Direct Comparison between the Behavioral Profiles of Knockout Mouse Lines.Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.Genetic deletion of the Histone Deacetylase 6 exacerbates selected behavioral deficits in the R6/1 mouse model for Huntington's disease.Disruption of response inhibition circuits in prodromal Huntington disease.Meclizine enhancement of sensorimotor gating in healthy male subjects with high startle responses and low prepulse inhibition.Moderate-level prenatal alcohol exposure enhances acoustic startle magnitude and disrupts prepulse inhibition in adult rhesus monkeys.Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.Neural correlates of sensorimotor gating: a metabolic positron emission tomography study in awake rats.Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegenerationHabituation and prepulse inhibition of acoustic startle in rodentsFine mapping of QTL for prepulse inhibition in LG/J and SM/J mice using F(2) and advanced intercross linesPrepulse inhibition in HIV-associated neurocognitive disorders.Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome.Ventral pallidum mediates amygdala-evoked deficits in prepulse inhibition.A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibitionPsilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.Altered palmitoylation and neuropathological deficits in mice lacking HIP14.Lamotrigine effects sensorimotor gating in WAG/Rij rats.Lesions of the dorsomedial striatum disrupt prepulse inhibition.Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP.Extended access to methamphetamine self-administration affects sensorimotor gating in rats.Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69LMice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease.Psychophysiological markers of vulnerability to psychopathology in men with an extra X chromosome (XXY).
P2860
Q24645703-EBE0EC5F-B3DC-4600-9311-0F372E5790C4Q26738436-190EA906-05B5-4CB0-BD68-D38A2F3FB6D4Q26774767-2AD477A4-138D-4229-9F2A-5A247C516E8EQ28071614-72C6D36D-A96D-4DB1-B05E-A5941258B537Q28078534-A167A5B7-B014-412C-8B1C-78BDADE43921Q28085253-64C31E59-910F-4970-87F6-D4850534A99CQ28217163-BAB8C59A-DA39-4B60-9BDC-F8C034D07BF4Q28304295-A4CEACAF-BB14-4488-B0C3-A4219C18D315Q28534633-6249276C-2944-463A-8E53-A83236F42555Q28728782-36CE2B00-A92B-47AF-B70A-3581C44424D6Q28741746-2799F664-E82F-498F-8B76-BCE12A0F9E2BQ30148819-3376DAFE-7FC6-4BBC-B865-F4F62D3BE50AQ30366139-EDF41F02-FB42-4E01-834C-41F423FAEAC1Q30378450-0EF536E3-9286-45A2-A6D6-D52A65EB85DBQ30390870-91B51C42-B541-43FC-A05B-556728CBA477Q30394589-896A23D0-E69D-4DB5-B0F9-868CA4A76E33Q30401432-CE5149F6-B77F-408F-A144-C384EEBE9A04Q30403689-DDD8C488-8ED6-431F-9F2E-F532DF8C332DQ30419962-4AA8FC81-5D56-49D5-9383-9FEA1ED60065Q30429488-4AA367E6-CEF8-4282-A18E-8B5DD7A1B0E0Q30435819-EB52BFCB-392A-4D13-A30C-A87C13AE6BD1Q30437145-6BB77228-BED1-447F-A335-8CE33E2C0CB2Q30446186-2E99D572-C568-4112-9EB2-02CB068E55E2Q30450016-F5AEC90A-1460-4DD2-9D74-A0D712CDFDDAQ30450454-ED591887-EE3B-42E2-941E-E3A662EA4ADFQ30451688-C15C60C2-22D4-4A7C-8490-C7482C2B5CA5Q30454136-638B4346-51B0-4F4B-86CC-20968C0EF991Q30455773-054A7AA7-0464-432A-A9C4-F6A78890D7B1Q30458199-AC52EF0F-4591-41DD-BA04-387B0D82D946Q30458275-A1A05591-D74C-40D3-BD85-47A5E3812242Q30458761-517DFE53-3E83-4CCA-8F7D-BDF72BFA5880Q30459497-DE02AC64-8FE2-46A8-862A-0680A1856566Q30462477-30920397-6FB6-4AD1-80EF-5A7271BE8746Q30464975-FED107CF-2E9A-42DF-AF10-AFBD616A93B7Q30468241-7F7DD3E5-6A89-42B0-A785-300C6E348E8FQ30469594-D77AF026-8BCA-4C96-8A83-FD0FB94C44EDQ30469898-692D5516-31D8-4BF3-839F-253B9AB76E6AQ30472097-EA06DBE0-659F-4DED-B9BE-FACEADCCAEB3Q30474047-23DF63D6-8A71-4594-977A-E9041E6D5EBBQ30475194-C6C5FE5C-8162-4A43-8CA6-5BCA972106C6
P2860
Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease.
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Impaired prepulse inhibition o ...... ents with Huntington's disease
@nl
Impaired prepulse inhibition o ...... nts with Huntington's disease.
@ast
Impaired prepulse inhibition o ...... nts with Huntington's disease.
@en
Impaired prepulse inhibition o ...... nts with Huntington's disease.
@en-gb
type
label
Impaired prepulse inhibition o ...... ents with Huntington's disease
@nl
Impaired prepulse inhibition o ...... nts with Huntington's disease.
@ast
Impaired prepulse inhibition o ...... nts with Huntington's disease.
@en
Impaired prepulse inhibition o ...... nts with Huntington's disease.
@en-gb
prefLabel
Impaired prepulse inhibition o ...... ents with Huntington's disease
@nl
Impaired prepulse inhibition o ...... nts with Huntington's disease.
@ast
Impaired prepulse inhibition o ...... nts with Huntington's disease.
@en
Impaired prepulse inhibition o ...... nts with Huntington's disease.
@en-gb
P2093
P2860
P3181
P356
P1476
Impaired prepulse inhibition o ...... nts with Huntington's disease.
@en
P2093
M R Swenson
N R Swerdlow
P2860
P304
P3181
P356
10.1136/JNNP.58.2.192
P407
P577
1995-02-01T00:00:00Z